Securities code: Betta Pharmaceuticals Co.Ltd(300558) securities abbreviation: Betta Pharmaceuticals Co.Ltd(300558) Announcement No.: 2022034 Betta Pharmaceuticals Co.Ltd(300558)
Announcement on 2021 profit distribution plan
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Betta Pharmaceuticals Co.Ltd(300558) (hereinafter referred to as "the company") held the 30th meeting of the third board of directors and the 24th Meeting of the third board of supervisors on April 1, 2022, and deliberated and adopted the profit distribution plan for 2021. Now the relevant specific contents are announced as follows:
1、 Basic information of profit distribution plan
According to the audit of Lixin Certified Public Accountants (special general partnership), the company's net profit attributable to the owner of the parent company in 2021 was 38306784044 yuan, of which the net profit of the parent company was 47878537689 yuan, the profit available for distribution to shareholders in that year was 47878537689 yuan, plus 206937223485 yuan of undistributed profit in previous years, plus 51515298 yuan of undistributed profit in previous years adjusted by changes in accounting policies, The total profit available for distribution at the end of 2020 is 12892503069 yuan, less the total profit available for distribution at the end of 2020.
The company's production and operation in 2021 are in good condition and its performance meets expectations. In order to better repay the majority of investors, on the premise of conforming to the principle of profit distribution and ensuring the normal operation and long-term development of the company, the profit distribution plan for 2021 is put forward as follows: Based on the total share capital of 415388667 shares, the company will distribute cash dividends of 2.50 yuan (including tax) to all shareholders for every 10 shares, with a total cash dividend of 10384716675 yuan; The remaining undistributed profits are carried forward and distributed in subsequent years. No conversion of accumulation fund into share capital.
If the total share capital of the company changes before the implementation of the distribution plan, the distribution proportion will be adjusted accordingly according to the principle that the total distribution amount remains unchanged.
2、 Explanation of the board of directors on the legality and compliance of profit distribution plan
The board of directors of the company believes that the profit distribution plan of the company in 2021 complies with the relevant requirements for profit distribution in the company law, the notice on further implementing the matters related to cash dividends of listed companies, the regulatory guidelines for listed companies No. 3 - cash dividends of listed companies and other laws and regulations, as well as the articles of association. The company has comprehensively considered the business performance, development stage, profitability and industry characteristics, and the profit distribution plan for 2021 is in line with the actual situation of the company on the premise of giving consideration to the reasonable return of investors and the long-term development of the company. There is no situation that damages the interests of the company and shareholders, especially small and medium-sized shareholders. The profit distribution plan is legal, compliant and reasonable.
The board of directors agreed to submit the 2021 profit distribution plan to the general meeting of shareholders for deliberation.
3、 Opinions of the board of supervisors
The board of supervisors of the company believes that the profit distribution plan for 2021 proposed by the company has fully considered the company's operating conditions, capital needs and future sustainable development, the interests and reasonable demands of investors, especially small and medium-sized investors, and complies with the relevant provisions of the company law and the articles of Association. It agrees to submit the proposal to the general meeting of shareholders of the company for deliberation.
4、 Opinions of independent directors
The independent directors of the company believe that the profit distribution plan of the company in 2021 complies with relevant laws and regulations and the relevant provisions of the articles of association, comprehensively considers the current actual operation status, development stage and profitability of the company, not only maintains the continuity and stability of profit distribution, but also reflects the reasonable investment return of the company to investors, and is conducive to the sustainable, stable and healthy development of the company. The independent directors of the company agreed to the profit distribution of the company in 2021 and agreed to submit the matter to the general meeting of shareholders for deliberation.
5、 Other instructions
The profit distribution plan for 2021 has been deliberated and approved at the 30th meeting of the third board of directors and the 24th Meeting of the third board of supervisors of the company. The independent directors have expressed their consent and need to be submitted to the general meeting of shareholders of the company for deliberation.
6、 Documents for future reference
1. Betta Pharmaceuticals Co.Ltd(300558) the resolution of the 30th meeting of the third board of directors;
2. Betta Pharmaceuticals Co.Ltd(300558) the resolution of the 24th Meeting of the third board of supervisors;
3. Betta Pharmaceuticals Co.Ltd(300558) independent directors' independent opinions on relevant matters of the 30th meeting of the third board of directors.
It is hereby announced.
Betta Pharmaceuticals Co.Ltd(300558) board of directors April 6, 2022
